The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.

Duh, Mei Sheng

The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. [electronic resource] - Disease management : DM Aug 2007 - 216-25 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1093-507X

10.1089/dis.2007.104649 doi


Adult
Anticonvulsants--economics
Cost Savings
Drug Costs--statistics & numerical data
Drug Prescriptions
Drug Utilization--economics
Drugs, Generic--economics
Epilepsy--drug therapy
Excitatory Amino Acid Antagonists
Female
Follow-Up Studies
Humans
Insurance, Health, Reimbursement--economics
Lamotrigine
Male
Prospective Payment System--economics
Quebec
Retrospective Studies
Triazines--economics